Howth, Ireland

Owen I Corrigan

This inventor holds 6 USPTO granted patents and 4 published patent applications. Top assignees: Elan Corporation, Plc, Elan Transdermal Limited. Active years: 1986-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Owen I Corrigan. Retrieved from https://idiyas.com/inventor/owen-i-corrigan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 355(Granted Patents)


Location History:

  • County Dublin, IE (1992)
  • Howth, IE (1986 - 1994)
  • Dublin, IE (1996)

Company Filing History:


Years Active: 1986-1996

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Innovator Owen I Corrigan: Pioneering Drug Delivery Solutions**

Introduction

Owen I Corrigan is a distinguished inventor based in Howth, Ireland, known for his significant contributions to the field of medicinal technology. With a total of six patents to his name, he has demonstrated a relentless pursuit of innovation, particularly in drug delivery systems designed to enhance patient outcomes.

Latest Patents

One of Owen I Corrigan's latest inventions is a **Passive Transdermal Device with Controlled Drug Delivery**. This groundbreaking method provides a preparation for the once-daily, percutaneous administration of nicotine, aimed at treating withdrawal symptoms associated with smoking. The device features nicotine uniformly distributed in a solid, semi-solid, or mucilaginous medium that can be placed in intimate contact with the skin. The formulation involves a careful mixture of nicotine with a gel-forming agent or mixture, prepared through appropriate heating or mixing techniques. This innovative approach assists in managing withdrawal symptoms and psychological dependence related to smoking cessation.

Career Highlights

Throughout his career, Owen has worked with prominent organizations, including Elan Transdermal Limited and Elan Corporation Plc. His experiences in these institutions reflect his commitment to advancing pharmaceutical technology and improving therapeutic interventions.

Collaborations

Owen I Corrigan has collaborated with various professionals, notably including John Corish and Yvonne B. Bannon. These partnerships have played a significant role in his inventive processes and have led to the development of impactful products in the drug delivery domain.

Conclusion

In conclusion, Owen I Corrigan stands out as an innovative force in the realm of pharmaceutical science. His contributions not only address pressing health concerns but also set the stage for future advancements in drug delivery systems. As his work continues to evolve, the impact of his inventions will undoubtedly benefit healthcare providers and patients alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…